Madaswamy S Muthu

TL;DR: This review summarizes the various nanocarriers developed so far in the literature for nanotheranostics, which include polymer conjugations, dendrimers, micelles, liposomes, metal and inorganic nanoparticles, carbon nanotubes, and nanoparticles of biodegradable polymers for sustained, controlled and targeted co-delivery of diagnostic and therapeutic agents for better theranostic effects with fewer side effects.

TL;DR: The targeting multi-functional liposome showed greater efficacy than the non-targeting liposomes and thus great potential to improve the cancer imaging and therapy.

TL;DR: This review is concerned with emerging targeted nanomedicines and multifunctional carriers capable of combining targeted drug delivery and imaging in the field of pharmaceutical applications and the significant toxicity issues associated with these nanomediines are explored.

TL;DR: A drug delivery system of liposomes, which are coated with D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS), a PEGylated vitamin E, with docetaxel as a model drug for enhanced treatment of brain tumour in comparison with the nudeliposomes as well as with the so-called stealth liposome, which have been intensive investigated in the literature.

TL;DR: Development of an advanced theranostic micelles of D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS), which are conjugated with transferrin for targeted co-delivery of docetaxel as a model drug and ultra bright gold clusters for simultaneous cancer imaging and therapy is developed.